In response to a lawsuit brought by a man who claimed that Covishield side effects were to blame for his daughter’s demise, the Bombay High Court has asked the Serum Institute of India (SII), Microsoft founder Bill Gates, and others for statements.
According to news agency ANI, the petitioner has asked for compensation from the vaccine maker in the amount of Rs 1,000 crore.
In his appeal, Dilip Lunawat claims that the government and other parties have distorted the truth about the COVID immunisation by making false claims about its safety and “forcing” doctors to get it.
Dilip Lunwat, a resident of Aurangabad, claimed that his daughter Snehal Lunawat, a medical student, was compelled to have the anti-Covid vaccination on January 28 of last year at her college in Nashik since she was a healthcare worker.
According to PTI, Snehal worked as a doctor and senior lecturer at the SMBT dentistry college and hospital in Dhamangaon.
She had received Covishield, a vaccination created by SII.
Days later, she complained of excruciating headaches and vomiting. She was taken to the hospital, where the doctors reportedly found bleeding in her brain. The claim states that Snehal passed away on March 1 as a result of negative vaccine side effects.
The petition was based on a report that the Center’s adverse events after immunisation (AEFI) committee presented on October 2.
The petitioner has also asked Bill and Melinda Gates Foundation, whose organisation has worked with the SII to hasten the production and distribution of 100 million doses of the vaccine, for a response. He also asked the state of Maharashtra, the Drug Controller General of India, and the Union government for their responses.
The petition stated that Lunwat sought justice for his daughter as well as “many more people who are going to be murdered” as a result of similar incidents with negative outcomes.
A division bench of Justices S V Gangapurwala and Madhav Jamdar served notice on all of the plea’s respondents on August 26. On November 17, there will be a hearing in this matter.